EARLY ACCESS CARE
Early Access Care provides consultative, functional, and operational support to biopharmaceutical companies for expanded access and compassionate use. They offer policy development, software as a solution, early access system, single patient, review committees, post-trial access, cohort compassionate use, and expanded access.
EARLY ACCESS CARE
Social Links:
Industry:
Clinical Trials Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Madison, Connecticut, United States
Country:
United States
Website Url:
http://www.earlyaccesscare.com
Total Employee:
101+
Status:
Active
Contact:
+1203 441 7938
Email Addresses:
[email protected]
Official Site Inspections
http://www.earlyaccesscare.com Semrush global rank: 2.81 M Semrush visits lastest month: 5.77 K
- Host name: 67.227.158.135
- IP address: 67.227.158.135
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "Early Access Care"
Early Access Care - Crunchbase Company Profile & Funding
Organization. Early Access Care . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Contact Email [email protected]; …See details»
Early Access Care LLC - VentureRadar
Website: https://www.earlyaccesscare.com/ Provides a platform connecting patients, physicians, and biopharmaceutical companies for expanded access/compassionate use ...See details»
Early Access Care, LLC | LinkedIn
Early Access Care is proud to support #ASCO24.Stop by our booth #23076 and speak with us about Expanded Access for your oncology program. EAC is a full-scale service provider with …See details»
Early Access Care - Overview, News & Competitors - ZoomInfo
Early Access Care contact info: Phone number: (203) 441-7938 Website: www.earlyaccesscare.com What does Early Access Care do? Early Access Care helps …See details»
Sign In - Early Access Care
Alternatively, contact Early Access Care at email: [email protected] or phone: US: +1 203 441 7938 EU: 00 203 441 7938. We will start the investigation immediately and will try …See details»
Early Access Care Selects Veeva Vault CDMS for Expanded Access …
Early Acce ss Care is a global organization accelerating access to investigational drug products for patients in need. Expanded access is the U.S. FDA process that gives patients access to ...See details»
Early Access Care Selects Veeva Vault CDMS - Veeva Systems
Aug 21, 2019 Early Access Care is a global organization accelerating access to investigational drug products for patients in need. Expanded access is the U.S. FDA process that gives …See details»
Expanded Access of Adagrasib (MRTX849) in Patients With …
[email protected]: Study Overview: This EAP is to provide expanded access of adagrasib (MRTX849) to patients with previously treated advanced solid …See details»
2025 Partners - Operationalize: Expanded Access Programs
Www.earlyaccesscare.com. Inceptua Early Access. ... Bionical Emas is a global Contract Research Organization (CRO) combining Clinical Development, Clinical Trial Supply (CTS) …See details»
Early Access Care - Connecting Patients with Investigational …
Welcome to Early Access Care. We use cookies to personalize content and to analyze our traffic. We also share information about your use of our site with Google Analytics to provide you with …See details»
Empowering Early Access to Investigational Medical Products
Enabling early access to investigational medical products. Our team's 30-year journey and expertise support patients in need. Learn more about Early Access Care.See details»
Early Access Care - Connecting Patients with Investigational …
BHV-0223. Biohaven Pharmaceuticals has developed a novel sublingual formulation of riluzole, BHV-0223, for the treatment of ALS. BHV-0223 (sublingual) dissolves under the tongue in …See details»
Partners - Operationalise Early Access Programmes Summit Europe
Www.earlyaccesscare.com. Expertise Partner: Inceptua Early Access is a global company specialising in the provision of Early Access Programs. With offices in 5 EU countries, the US, …See details»
Our Mission: Accelerate Access to Investigational Drugs - Early …
Welcome to Early Access Care. We use cookies to personalize content and to analyze our traffic. We also share information about your use of our site with Google Analytics to provide you with …See details»
Compassionate Use - Syndax
In the United States, physicians interested in treating a patient with revumenib (SNDX-5613) can reach out to [email protected].. Outside the United States, physicians …See details»
Expanded Access of Adagrasib (MRTX849) in Patients With …
Mirati.ExpandedAccess@ earlyaccesscare.com: OVERVIEW – in layman’s terms (150 words max) This EAP is to provide expanded access of adagrasib (MRTX849) to patients with …See details»
Strategic Collaborations That Transform Early Access To Medicines
Apr 8, 2021 House Approves ‘Right-To-Try’ Bill in a Vote of 267-149 Mar 22, 2018See details»
Expanded Access & Experimental Drugs for Patients - Early Access …
What We Do. If an experimental medicine is available for early access, and Early Access Care is the service provider managing the requests on behalf of the pharmaceutical company, Early …See details»
The Early Access System | Early Access Care
We value your privacy and online security. Inquiries directed from ClinicalTrials.gov, Reagan-Udall Navigator, or your pharmaceutical company’s website can be directed to the Early Access …See details»